marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Regulus Therapeutics Balance Sheet 2011-2024 | RGLS
Annual Balance Sheet Regulus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22 M | -21.8 M | -55.7 M | -26.4 M | -19.5 M | 2.64 M | 6.34 M | 66 M | -16 M | 9.47 M | 89.7 M | 27.1 M | 1.64 M |
Long Term Debt |
1.06 M | 1.77 M | 4.67 M | - | - | - | - | 19.8 M | - | 23.4 M | 11.3 M | 10.1 M | 10 M |
Long Term Debt Current |
713 K | 649 K | 589 K | 417 K | 361 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 468 K | 7.14 M | 9.99 M | 30.8 M | 4.37 M | 4.27 M | 19.2 M | 28.7 M | 71.5 M |
Total Current Liabilities |
8.51 M | 11.7 M | 5.23 M | 11.6 M | 21.6 M | 26.6 M | 32.6 M | 13.8 M | 12.6 M | 35.2 M | 10.4 M | 12.8 M | - |
Total Liabilities |
9.56 M | 13.4 M | 13.5 M | 11.6 M | 22.1 M | 33.8 M | 42.6 M | 44.6 M | 17 M | 39.5 M | 29.6 M | 41.4 M | 84.4 M |
Deferred Revenue |
- | - | - | - | 6 K | 2.57 M | 72 K | 72 K | 1.19 M | 3.1 M | 4.89 M | 10.5 M | 10.7 M |
Retained Earnings |
-513 M | -483 M | -455 M | -427 M | -411 M | -393 M | -346 M | -273 M | -192 M | -136 M | -79.1 M | -60.4 M | -43 M |
Total Assets |
30.8 M | 46.7 M | 68.5 M | 37.6 M | 42.1 M | 27.9 M | 77.8 M | 101 M | 141 M | 171 M | 123 M | 104 M | 42.9 M |
Cash and Cash Equivalents |
23.8 M | 24.2 M | 60.4 M | 31.1 M | 34.1 M | 13.9 M | 13.5 M | 14.9 M | 16 M | 37.3 M | 17.8 M | 40.6 M | 9.18 M |
Book Value |
21.2 M | 33.3 M | 55 M | 26 M | 20 M | -5.85 M | 35.2 M | 56.1 M | 124 M | 132 M | 93.5 M | 62.1 M | -41.5 M |
Total Shareholders Equity |
21.2 M | 33.3 M | 55 M | 26 M | 20 M | -5.85 M | 35.2 M | 56.1 M | 124 M | 132 M | 93.5 M | 62.1 M | -41.5 M |
All numbers in USD currency
Quarterly Balance Sheet Regulus Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
476 K | 675 K | 868 K | 1.06 M | 1.24 M | 1.42 M | 1.6 M | 1.77 M | - | 2.79 M | 3.59 M | 4.67 M | 2.57 M | 2.72 M | 2.87 M | - | - | - | - | 56 K | 114 K | 200 K | 245 K | - | - | - | - | - | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.96 M | 5.94 M | 6.55 M | 9.56 M | 9.49 M | 9.65 M | 10.4 M | 13.4 M | - | 11.9 M | 11.7 M | 13.5 M | 14 M | 12.7 M | 12.7 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 33.8 M | 33.8 M | 33.8 M | 33.8 M | 42.6 M | 42.6 M | 42.6 M | 42.6 M | 44.6 M | 44.6 M | 44.6 M | 44.6 M | 17 M | 17 M | 17 M | 17 M | 39.5 M | 39.5 M | 39.5 M | 39.5 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 41.7 M | 41.7 M | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6 K | 6 K | 6 K | 6 K | 2.57 M | 2.57 M | 2.57 M | 2.57 M | 72 K | 72 K | 72 K | 72 K | 72 K | 72 K | 72 K | 72 K | 1.19 M | 1.19 M | 1.19 M | 1.19 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 4.89 M | 4.89 M | 4.89 M | 4.89 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 10.7 M | 10.7 M | - | - |
Retained Earnings |
-547 M | -533 M | -522 M | -513 M | -505 M | -497 M | -490 M | -483 M | - | -469 M | -462 M | -455 M | -448 M | -439 M | -433 M | -427 M | -427 M | -427 M | -427 M | -411 M | -411 M | -411 M | -411 M | -393 M | -393 M | -393 M | -393 M | -346 M | -346 M | -346 M | -346 M | -273 M | -273 M | -273 M | -273 M | -192 M | -192 M | -192 M | -192 M | -136 M | -136 M | -136 M | -136 M | -79.1 M | -79.1 M | -79.1 M | -79.1 M | -60.4 M | -60.4 M | -60.4 M | -60.4 M | -43 M | -43 M | - | - |
Total Assets |
93.8 M | 104 M | 114 M | 30.8 M | 37.7 M | 43.6 M | 37 M | 46.7 M | - | 54.3 M | 61 M | 68.5 M | 43 M | 49.5 M | 39.8 M | 37.6 M | 37.6 M | 37.6 M | 37.6 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 27.9 M | 27.9 M | 27.9 M | 27.9 M | 77.8 M | 77.8 M | 77.8 M | 77.8 M | 101 M | 101 M | 101 M | 101 M | 141 M | 141 M | 141 M | 141 M | 171 M | 171 M | 171 M | 171 M | 123 M | 123 M | 123 M | 123 M | 104 M | 104 M | 104 M | 104 M | 42.9 M | 42.9 M | - | - |
Cash and Cash Equivalents |
26.4 M | 17.1 M | 29.6 M | 23.8 M | 25.8 M | 37.3 M | 30.3 M | 24.2 M | 20 M | 35.1 M | 53.9 M | 60.4 M | 35.8 M | 41.4 M | 31.6 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | 34.1 M | 34.1 M | 34.1 M | 34.1 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 16 M | 16 M | 16 M | 16 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 40.6 M | 40.6 M | 40.6 M | 40.6 M | 9.18 M | 9.18 M | - | - |
Book Value |
86.8 M | 98.2 M | 108 M | 21.2 M | 28.3 M | 34 M | 26.6 M | 33.3 M | - | 42.4 M | 49.2 M | 55 M | 29 M | 36.8 M | 27.1 M | 26 M | 26 M | 26 M | 26 M | 20 M | 20 M | 20 M | 20 M | -5.85 M | -5.85 M | -5.85 M | -5.85 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 56.1 M | 56.1 M | 56.1 M | 56.1 M | 124 M | 124 M | 124 M | 124 M | 132 M | 132 M | 132 M | 132 M | 93.5 M | 93.5 M | 93.5 M | 93.5 M | 62.1 M | 62.1 M | 62.1 M | 62.1 M | 1.2 M | 1.2 M | - | - |
Total Shareholders Equity |
86.8 M | 98.2 M | 108 M | 21.2 M | 28.3 M | 34 M | 26.6 M | 33.3 M | 39.7 M | 42.4 M | 49.2 M | 55 M | 29 M | 36.8 M | 27.1 M | 26 M | 26 M | 26 M | 26 M | 20 M | 20 M | 20 M | 20 M | -5.85 M | -5.85 M | -5.85 M | -5.85 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 56.1 M | 56.1 M | 56.1 M | 56.1 M | 124 M | 124 M | 124 M | 124 M | 132 M | 132 M | 132 M | 132 M | 93.5 M | 93.5 M | 93.5 M | 93.5 M | 62.1 M | 62.1 M | 62.1 M | 62.1 M | -41.5 M | -41.5 M | - | - |
All numbers in USD currency